4.6 Review

Is early-onset cancer an emerging global epidemic? Current evidence and future implications

Journal

NATURE REVIEWS CLINICAL ONCOLOGY
Volume 19, Issue 10, Pages 656-673

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41571-022-00672-8

Keywords

-

Categories

Funding

  1. U.S. National Institutes of Health [R35 CA197735, R01 CA248857]
  2. Cancer Research UK Cancer Grand Challenge Award [6340201/A27140]
  3. Prevent Cancer Foundation, Japan Society for the Promotion of Science
  4. Mishima Kaiun Memorial Foundation

Ask authors/readers for more resources

The incidence of early-onset cancers (diagnosed in individuals <50 years of age) has increased in many countries in recent decades. This increase is probably due to greater use of screening programs and changing patterns in early-life exposures. Evidence suggests that risk factor exposures in early life and young adulthood play an etiological role in the development of these cancers.
The incidence of early-onset forms of many cancers (defined as cancers diagnosed in individuals <50 years of age) has increased in a number of countries over the past several decades. The underlying reasons for this apparent increase probably include greater use of screening programmes, but also changing patterns in early-life exposures. In this Review, the authors describe the emerging global increase in the incidence of early-onset cancers and suggest changes that might address this situation. Over the past several decades, the incidence of early-onset cancers, often defined as cancers diagnosed in adults <50 years of age, in the breast, colorectum, endometrium, oesophagus, extrahepatic bile duct, gallbladder, head and neck, kidney, liver, bone marrow, pancreas, prostate, stomach and thyroid has increased in multiple countries. Increased use of screening programmes has contributed to this phenomenon to a certain extent, although a genuine increase in the incidence of early-onset forms of several cancer types also seems to have emerged. Evidence suggests an aetiological role of risk factor exposures in early life and young adulthood. Since the mid-20th century, substantial multigenerational changes in the exposome have occurred (including changes in diet, lifestyle, obesity, environment and the microbiome, all of which might interact with genomic and/or genetic susceptibilities). However, the effects of individual exposures remain largely unknown. To study early-life exposures and their implications for multiple cancer types will require prospective cohort studies with dedicated biobanking and data collection technologies. Raising awareness among both the public and health-care professionals will also be critical. In this Review, we describe changes in the incidence of early-onset cancers globally and suggest measures that are likely to reduce the burden of cancers and other chronic non-communicable diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available